Singapore, 27 December 2017 – SingHealth today announced key leadership changes atthe SingHealth Duke-NUS Academic Medical Centre and National Cancer Centre Singapore.Professor Soo Khee Chee, Deputy Group Chief Executive Officer (Research & Education),SingHealth; Director, National Cancer Centre Singapore (NCCS) and Academic Chair,SingHealth Duke-NUS Oncology Academic Clinical Programme; will retire from SingHealthon 31 December 2017. He relinquished the appointment as Director of NCCS, with effectfrom 26 November 2017.
As SingHealth’s Deputy Group Chief Executive Officer (Research & Education), ProfessorSoo built a strong academic culture, laid a strong research foundation and steered numerouscollaborations with industry partners that catalysed research in the public healthcare sectorthat translated to improvements in clinical care.
Professor Soo was one of the prime movers whose tireless efforts culminated in SingHealthpartnering Duke University and bringing Duke-NUS Medical School to SGH Campus andSingapore. In partnership with Duke-NUS, he led the establishment of Academic ClinicalProgrammes and numerous joint institutes including the Academic Medicine EducationInstitute and Academic Medicine Research Institute, which have facilitated learning andexchange.
The founding Director of NCCS since 1998, Professor Soo led its growth and developmentto be a leading cancer institution renowned both locally and internationally. Under hisleadership, NCCS introduced a multi-disciplinary and holistic approach to cancermanagement. For its commitment to excellence in patient care, research and education,NCCS was awarded the Singapore Service Excellence Medallion in 2015.
With a passion for nurturing the next generation, Professor Soo has personally mentoredand inspired generations of successful clinicians. On the research front, clinician scientistsunder Professor Soo’s guidance have achieved numerous breakthroughs through theirresearch pursuits, translating basic findings into clinical applications. As a result, NCCS iswidely recognised for its research in lymphoma, head and neck, nasopharyngeal, liver andlung cancers.
In recognition of his many contributions to medicine, research and education, Professor Sooreceived several prestigious awards, including the National Day Award Public AdministrationMedal (Gold) in 2003, National Outstanding Clinician Mentor Award in 2008 and President’sScience and Technology Medal in 2011. He also holds the distinction of being the firstrecipient to be conferred the Duke-NUS Medical School Benjamin Sheares Professorship inAcademic Medicine in 2011.
Professor Soo was also instrumental in attracting major philanthropic gifts, including the giftof $50 million from the Goh Foundation to set up the Goh Cheng Liang Proton TherapyCentre at the new NCCS building, which is targeted to be ready by 2022.
“Khee Chee’s distinguished career in public healthcare has earned him respect as avisionary clinician-leader, outstanding surgeon and researcher. His foresight and mastery inbuilding a sustainable research ecosystem and gaining philanthropic support has enabledthe growth of the SingHealth Duke-NUS Academic Medical Centre. His passion foradvancing medicine, developing people and most of all, patient care, is inspirational. We arepleased that he will continue to practice at NCCS and share his wealth of experience withus,” said Professor Ivy Ng, Group Chief Executive Officer, SingHealth.
Professor Soo will continue to contribute as Senior Visiting Consultant at NCCS andSingHealth, and remain as Lead Principal Investigator in the Tan Chin Tuan Laboratory ofOptical Imaging and Photodynamic Therapy of Cancer, NCCS.
"I am grateful to my colleagues, patients, well-wishers and donors who have supported meduring my time at NCCS and SingHealth. I am pleased to continue to be associated withboth organisations after my retirement and look forward to contributing to clinical andresearch work, education as well as philanthropy work," said Professor Soo.
Deputy Group Chief Executive Officer (Research & Education), SingHealth(with effect from 1 January 2018)
Professor Wong Tien Yin will be appointed Deputy Group Chief Executive Officer (Research& Education), SingHealth with effect from 1 January 2018. A highly respected clinicianleader with a strong leadership track record, Professor Wong is also Medical Director ofSingapore National Eye Centre (SNEC) and Academic Chair, SingHealth Duke-NUSOphthalmology and Visual Sciences Academic Clinical Programme. He has previouslyserved as Group Director, Research, SingHealth as well as Executive Director of theSingapore Eye Research Institute (SERI), where he continues to chair the Board.
An internationally renowned ophthalmologist specialising in retinal diseases, in particulardiabetic retinopathy and age-related macular degeneration, Professor Wong’s academic andresearch work has been recognised with numerous awards. He is a two-time recipient of theSingapore Translational Research (STaR) Investigator Award in 2008 and 2014. In 2010, hereceived the National Outstanding Clinician Scientist Award and the President’s ScienceAward. In addition, he was selected for the 2013 Eisenhower Fellowship to the USA andreceived the President’s Technology Award in 2014.
Medical Director, National Cancer Centre Singapore(effective from 26 November 2017)
Associate Professor William Hwang Ying Khee was appointed Medical Director of NCCSand Academic Chair, SingHealth Duke-NUS Oncology Academic Clinical Programme,effective from 26 November 2017.
A respected clinician leader, Associate Prof Hwang has a strong track record of multipleleadership portfolios having previously served as Director, SingHealth Transplant; Head,SingHealth Duke-NUS Blood Cancer Centre; Head, Department of Haematology, SingaporeGeneral Hospital, Medical Director, Singapore Cord Blood Bank and President of the WorldMarrow Donor Association.
He is an avid researcher recognised for his expertise in haematological malignancies, especially in the areas of Haemato-Oncology and Stem Cell Transplantation. He currentlychairs the Chapter of Haematologists, Singapore and the Workgroup on Biobanking for theMinistry of Health. He is also a member of the Advisory Committee for the Centre forInternational Blood and Marrow Transplant Research and an Executive Board member ofthe Asia Pacific Blood and Marrow Transplant Group (APBMT).
Subscribe to our mailing list to get the updates to your inbox